Xiaoyuan Chen
Biomedical Engineering · 2006–2020
A researcher in the Science corpus: 27 papers; trusts 15 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Biomedical Engineering — 459 citations into it; #5,032 of 10,734 by trust here, #475 by citations
- Molecular Biology — 436 citations into it; #13,691 of 17,773 by trust here, #3,835 by citations
- Materials Chemistry — 334 citations into it; #7,764 of 11,513 by trust here, #3,001 by citations
- Electronic, Optical and Magnetic Materials — 154 citations into it
- Cancer Research — 89 citations into it
- Radiology, Nuclear Medicine and Imaging — 48 citations into it
- Biophysics — 24 citations into it
Whom Xiaoyuan Chen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Xiaoyuan Chen overall
Papers from Xiaoyuan Chen's perspective
Ordered by how strongly the researchers Xiaoyuan Chen trusts endorse each paper. Same corpus, a different order for every researcher.
- Renal clearance of quantum dots (Nature Biotechnology)
- Long-circulating and target-specific nanoparticles: theory to practice. (Pharmacological Reviews)
- Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. (Proceedings of the National Academy of Sciences of the United States of America)
- Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. (Toxicology Letters)
- Multiplexed electrical detection of cancer markers with nanowire sensor arrays (Nature Biotechnology)
- RNA-Guided Human Genome Engineering via Cas9
- Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. (Toxicological Sciences)
- Nanomedicine: current status and future prospects (The FASEB Journal)
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Their papers
- Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy (2008) — 1,078 citations
- In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. (2020) — 1,421 citations
- Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. (2006) — 906 citations
- Drug delivery with carbon nanotubes for in vivo cancer treatment (2008) — 2,066 citations
- Carbon nanotubes as photoacoustic molecular imaging agents in living mice (2008) — 1,175 citations
- Structural and functional photoacoustic molecular tomography aided by emerging contrast agents (2014) — 307 citations
- Nanoparticle-based theranostic agents (2010) — 1,321 citations
- Emerging Strategies of Cancer Therapy Based on Ferroptosis (2018) — 669 citations
- Light-Triggered Theranostics Based on Photosensitizer-Conjugated Carbon Dots for Simultaneous Enhanced-Fluorescence Imaging and Photodynamic Therapy (2012) — 651 citations
- Engineering Macrophages for Cancer Immunotherapy and Drug Delivery (2020) — 789 citations
- The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy (2020) — 698 citations
- Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases (2020) — 731 citations
- Clinical development and potential of photothermal and photodynamic therapies for cancer (2020) — 2,692 citations
- Photothermal Therapy and Photoacoustic Imaging via Nanotheranostics in Fighting Cancer (2019) — 1,709 citations
- Near-infrared-II molecular dyes for cancer imaging and surgery (2019) — 721 citations
- Synthesis of Copper Peroxide Nanodots for H2O2 Self-Supplying Chemodynamic Therapy. (2019) — 890 citations
- Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) — 343 citations
- Simultaneous Fenton-like Ion Delivery and Glutathione Depletion by MnO2 -Based Nanoagent to Enhance Chemodynamic Therapy. (2018) — 1,340 citations
- Nanoparticles design strategies for enhanced anticancer therapy by exploiting tumour microenvironment (2017) — 600 citations
- Nanotechnology for Multimodal Synergistic Cancer Therapy. (2017) — 1,496 citations